COMMUNIQUÉS West-GlobeNewswire

ALX Oncology to Report Second Quarter 2025 Financial Results on August 12, 2025
05/08/2025
SOUTH SAN FRANCISCO, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies [...]
CervoMed to Participate in the Canaccord Genuity 45th Annual Growth Conference
05/08/2025
BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that Company management will [...]
Vireo Growth Inc. to Release Second Quarter 2025 Results on August 13, 2025
05/08/2025
MINNEAPOLIS, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), today announced that it will release its financial results for its second fiscal quarter ended June [...]
Izotropic’s IzoView Positioned to Capitalize on Key Global Breast Imaging Market Drivers
05/08/2025
- Global breast imaging market projected to reach $8.69 billion by 2030, with IzoView addressing key clinical and commercial trends driving demand - Company positioned to lead in dense breast imaging, where rising [...]
IMUNON Reports Second Quarter 2025 Financial Results and Provides Business Update
05/08/2025
Stock dividend issued to IMUNON shareholders reflects confidence in clinical programs, long-term growth strategy and dedication to rewarding shareholders First patient dosed in Phase 3 OVATION 3 Study of IMNN-001 for [...]
InspireMD Reports Second Quarter 2025 Financial Results
05/08/2025
--- Management to host investor conference call today, August 5 th , at 8:30am ET --- MIAMI, Aug. 05, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard ® Prime carotid stent system for the [...]
Tecan schedules conference call on August 12th to discuss half year 2025 financial results
05/08/2025
Männedorf, Switzerland, August 5, 2025 – The Tecan Group AG (SIX Swiss Exchange: TECN) will hold a conference call to discuss the financial results for the first half year 2025 on Tuesday, August 12th, 2025 at 08:30 [...]
Mesa Labs Announces First Quarter Results
05/08/2025
LAKEWOOD, Colo., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced [...]
HOOPP launches 2030 Strategic Plan to build a stronger financial future for Ontario’s healthcare community
05/08/2025
Five-year plan seeks to drive member value and portfolio resilience TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- The Healthcare of Ontario Pension Plan (HOOPP) is proud to announce the launch of its 2030 Strategic Plan, a [...]
CHO Plus Enters into Project Agreement with BARDA’s BioMaP Consortium to Develop High Productivity Cell Lines for Filovirus Monoclonal Antibody Production
05/08/2025
SOUTH SAN FRANCISCO, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Privately held CHO Plus, Inc. announced today a project agreement awarded from the Biomedical Advanced Research and Development Authority’s (BARDA) [...]
Vivani Medical Announces Rapid Advancement of NPM-139, a Novel Semaglutide Implant, Following Positive Weight Loss Data from an Ongoing Preclinical Study of NPM-139 and Promising Results from the LIBERATE-1 Phase 1 Clinical Study of NPM-115
05/08/2025
LIBERATE-1, the first-in-human application of Vivani’s NanoPortal TM implant technology, showed a positive safety and tolerability profile, along with encouraging performance data for NPM-115 that met the study’s [...]
Clearmind Medicine Receives IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center
05/08/2025
IRB Approval from Hadassah Medical Center Follows FDA IND Clearance and Prior Approvals from Additional Clinical Sites Vancouver, Canada, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: [...]
Asklepion Pharmaceuticals Signs Contract to Utilize NetraMark Technology in Phase III Pediatric Cardiac Study
05/08/2025
TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company transforming clinical trials [...]
Bioma Probiotics Launches Science-Backed Gut Health Formula for Women’s Natural Weight Loss
05/08/2025
Discover how Bioma Probiotics supports weight loss, balances gut health, and helps women reduce bloating, boost energy, and improve digestion naturally. Backed by science. New York City, NY, Aug. 05, 2025 (GLOBE [...]
SERB Pharmaceuticals Agrees to Acquire Y-mAbs Therapeutics
05/08/2025
Acquisition to Include DANYELZA ® ( Naxitamab-gqgk) , Further Broadening SERB’s Rare Oncology Product Portfolio Transaction Expands SERB’s Investment in the U.S. SERB to Commence All-Cash Tender Offer to Acquire All [...]
Conduit to Change Name to CDT Equity Inc.
05/08/2025
Name change to CDT Equity Inc. reflects evolution of strategy and focus on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation, strategic partnerships and out-licensing [...]
Assertio Holdings, Inc. to Report Second Quarter 2025 Financial Results on August 11, 2025
05/08/2025
LAKE FOREST, Ill., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that it will release second quarter 2025 financial results on Monday, August 11, [...]
Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities
05/08/2025
Strengthens Balance Sheet and Continues Commercialization Readiness Plans for the LIBERTY® System as it Nears FDA Marketing Clearance Decision HINGHAM, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. ( [...]
NeurAxis to Host Second Quarter 2025 Results and Business Update Call on Tuesday, August 12, 2025
05/08/2025
Financial results to be released before market open; Conference call to be conducted at 9:00 a.m. Eastern Time CARMEL, Ind., Aug. 05, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American [...]

Pages